Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
In Vivo ; 19(3): 495-500, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15875767

RESUMEN

The purpose of this study was to evaluate the modifying effects of electroacupuncture (EA) and moxibustion (Mox) through the communication networks of the neuroimmune system using the two-step bacterial stimulation method. When EA or Mox treatment was implemented immediately following injection of the Streptococcus pyogenes preparation OK-432, a significant suppression of the tumor necrosis factor (TNF)alpha production by the peritoneal macrophages induced by lipopolysaccharide (LPS 1 microg/ml) was observed. When the stimulation with EA or Mox was reduced in volume, the degree of suppression decreased correspondingly. Naloxone antagonized to some extent the suppression of TNFalpha induced by EA, but did not compete with the suppression of TNFalpha release induced by Mox. These results suggest that activated macrophages are an important target of the immuno-suppressive effects of EA and Mox and that mu-opioid receptor-mediated mechanisms are responsible, to some extent, for the suppressive effect of EA, although Mox may not be dependent on these mechanisms.


Asunto(s)
Electroacupuntura , Lipopolisacáridos/farmacología , Macrófagos Peritoneales/inmunología , Moxibustión , Factor de Necrosis Tumoral alfa/biosíntesis , Animales , Citocinas/biosíntesis , Cinética , Macrófagos Peritoneales/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Naloxona/farmacología , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
2.
Gan To Kagaku Ryoho ; 30(7): 951-5, 2003 Jul.
Artículo en Japonés | MEDLINE | ID: mdl-12894709

RESUMEN

We used a new combination chemotherapy with nedaplatin (CDGP) and 5-fluorouracil (5-FU) in eleven fresh patients with oral squamous cell carcinomas. 5-FU was administered at a dose of 1,000 mg/body by continuous infusion for 24 hours on days 1 to 5. CDGP was administered at a dose of 80 or 100 mg/m2 by drip infusion for 120 minutes on day 5. The response rates of total (1- or 2-course) and 2-course group were 54. 5% and 83.3%, respectively. Adverse drug reactions were limited to two cases of grade 3 toxicity with anorexia. The combination chemotherapy with 5-FU and CDGP in place of cisplatin and 5-FU seemed to play an important role as neo-adjuvant chemotherapy for oral squamous cell carcinomas.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Neoplasias de la Boca/tratamiento farmacológico , Anciano , Esquema de Medicación , Femenino , Fluorouracilo/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Compuestos Organoplatinos/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...